Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

OPD - Charlemagne Capital - Replacement

30 Sep 2016 15:01

RNS Number : 3915L
Charlemagne Capital Limited
30 September 2016
 

 

The following replaces the 'Form 8 (OPD) Charlemagne Capital plc' released on 30 September 2016 at 07.00 under RNS No 2771L.

 

The opening two paragraphs in italics have been included and reference to Form "8" removed.

 

The full amended text is shown below:

 

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

 

Charlemagne Capital has its registered office in Cayman and is not subject to the UK City Code on Takeovers and Mergers (the "Code"). Accordingly the Code does not apply to the Offer by Fiera Capital for Charlemagne Capital and this transaction is not subject to the jurisdiction of, or being regulated by, the UK Panel on Takeovers and Mergers (the "Takeover Panel"). However, Charlemagne Capital and Fiera Capital have agreed, to the extent set out in the Implementation Agreement, that they will conduct themselves and the Offer as if the Offer were subject to the Code.

 

Disclosures made in relation to relevant securities of Charlemagne Capital should be released via a Regulatory Information Service using the headline "Document re: Charlemagne Capital". The headline "Form 8/8.3"should not be used. Any question regarding completion of these forms should be raised with N+1 Singer (tel: +44 (0) 20 7496 3000). Charlemagne Capital Shareholders and persons considering the acquisition or disposal of any interest in Charlemagne Capital Shares are reminded that they are subject to the Disclosure and Transparency Rules made by the UKLA and other applicable regulatory rules regarding transactions in Charlemagne Capital Shares.

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Charlemagne Capital Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Charlemagne Capital Limited

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

27 September 2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Interests held by directors of Charlemagne Capital Limited:

 

Director

Shareholding

Percentage holding

James Mellon(1)

55,669,497

19.14

Jayne Sutcliffe(2)

31,708,519

10.90

Jane McAndry

1,266,719

0.44

Lloyd Jones

1,196,938

0.41

Michael Baer

800,000

0.28

Jacob Johan (Jaap) van Duijn

200,000

0.07

Rt Hon Lord Lang of Monkton, PC

100,000

0.03

 

(1) A number of shares included in this holding are held by Galloway Limited, Indigo Securities Limited and Burnbrae Limited, which are each indirectly wholly owned by the trustee of a settlement under which James Mellon has a life interest.

(2) A number of shares included in this holding are held on behalf of the trustees of discretionary trusts, under which Jayne Sutcliffe and members of her family may become beneficiaries.

 

Interests held by directors of subsidiary companies wholly owned by Charlemagne Capital Limited:

 

Director

Shareholding

Percentage holding

Varda Lotan3

4,107,924

1.41

Anderson Whamond4

3,200,000

1.10

Julian Mayo

1,457,864

0.50

Vicky Kydoniefs

371,511

0.13

 

(3) A number of shares included in this holding are held on behalf of the trustees of discretionary trusts, under which Varda Lotan and members of her family may become beneficiaries.

(4) A number of shares included in this holding are held on behalf of the trustees of a pension plan, under which Anderson Whamond and members of his family may become beneficiaries.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form (Open Positions)

NO

Supplemental Form (SBL)

NO

 

 

Date of disclosure:

30 September 2016

Contact name:

Jane McAndry

Telephone number:

01624 640 216

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEWGUAABUPQGWU
Date   Source Headline
15th Apr 20113:55 pmRNSAnnual Report and Notice of AGM
7th Apr 20117:00 amRNSAssets under Management as at 31 March 2011
24th Mar 20119:48 amRNSDirectorate Change
4th Mar 20117:30 amRNSDividend Declaration
4th Mar 20117:00 amRNSFinal Results
14th Jan 20114:35 pmRNSPrice Monitoring Extension
14th Jan 201110:54 amRNSChange of Adviser
11th Jan 20117:00 amRNSTrading Statement
20th Oct 20104:35 pmRNSPrice Monitoring Extension
20th Oct 20104:35 pmRNSPrice Monitoring Extension
6th Oct 20107:00 amRNSAUM Update
7th Sep 20107:00 amRNSDividend Declaration
7th Sep 20107:00 amRNSHalf Yearly Report
2nd Sep 20109:00 amRNSCharlemagne Capital awarded SAS 70 certification
9th Jul 20107:00 amRNSTrading Statement
1st Jun 20109:09 amRNSDirectorate Change
17th May 20102:32 pmRNSResult of AGM
19th Apr 201011:29 amRNSAnnual Report and Notice of AGM
7th Apr 20107:00 amRNSQ1 2010 AUM Update
23rd Mar 20109:34 amRNSDirectorate Change
11th Mar 20107:01 amRNSDividend Declaration
11th Mar 20107:00 amRNSFinal Results
25th Jan 20105:44 pmRNSHolding(s) in Company
22nd Jan 201011:00 amRNSHolding(s) in Company
12th Jan 20109:30 amRNSReplacement Trading Statement
12th Jan 20107:00 amRNSTrading Statement
29th Dec 20097:30 amRNSPurchase of Own Shares for Cancellation
24th Dec 20097:01 amRNSPurchase of Own Shares for Cancellation
30th Oct 200910:56 amRNSHolding(s) in Company
6th Oct 20097:00 amRNSAssets under Management
5th Oct 20093:34 pmRNSDirector's Interest in Shares
24th Sep 20094:27 pmRNSReplacement - Half Yearly Report
23rd Sep 20097:00 amRNSDividend Declaration
23rd Sep 20097:00 amRNSHalf Yearly Report
21st Jul 200910:22 amRNSRule 8.3- Kazakhgold Group Limited
20th Jul 200910:34 amRNSRule 8.3- Kazakhgold Group Limited
15th Jul 200911:05 amRNSRule 8.3- Kazakhgold Group Limited
14th Jul 200910:06 amRNSRule 8.3- Kazakhgold Group Limited
13th Jul 200910:54 amRNSRule 8.3- Kazakhgold Group Limited
9th Jul 20097:00 amRNSTrading Statement
3rd Jul 200912:15 pmRNSRule 8.3- Kazakhgold Group Limited
2nd Jul 20094:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20094:35 pmRNSPrice Monitoring Extension
1st Jul 200912:34 pmRNSRule 8.3 - Kazakhgold Group Limited
26th Jun 200910:47 amRNSRule 8.3- Kazakhgold Group Limited
23rd Jun 200912:01 pmRNSRule 8.3- Kazakhgold Group Limited
18th Jun 20092:51 pmRNSHolding(s) in Company
18th Jun 200911:57 amRNSRule 8.3- Kazakhgold Group Limited
4th Jun 20094:40 pmRNSSecond Price Monitoring Extn
4th Jun 20094:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.